Y Fujitani, A Trifilieff, S Tsuyuki, AJ Coyle and C Bertrand
Department of Respiratory Diseases and Allergy, Ciba-Geigy Ltd., Basel, Switzerland.

In this study, we have examined the effect of endothelin (ET) receptor antagonists on lung granulocyte inflammation after antigen challenge in sensitized mice. The antagonists used were BQ-123, an ETA antagonist, BQ-788, an ETB antagonist, and SB209670, an ET(A&B) antagonist. Thirty minutes prior exposure to aerosolized ovalbumin, ET antagonists (50 pmol/mouse) were administered directly into the lungs of sensitized Balb/c mice via the intranasal route. BQ-123 and SB209670 significantly decreased eosinophil number in the bronchoalveolar lavage fluid by 47 and 68%, respectively. Both compounds also inhibited neutrophil infiltration into the lungs. In contrast, BQ-788 did not affect granulocyte infiltration. A similar inhibition of lung eosinophilia was also obtained with an anti-ET antibody applied via the intranasal route. BQ-123 and SB209670, but not BQ-788, significantly increased the production of interferon-gamma (Th1 cytokine) from purified lung Thy1.2+ cells without affecting interleukin-4 and interleukin-5 (Th2 cytokines) secretion. Furthermore, neutralizing antibody against interferon-gamma prevented the inhibitory effect of the ETA antagonist. Taken together, these results suggest an important pathophysiologic role for ET in the development of lung inflammation in asthma and highlight the potential of ET antagonists for the treatment of the disease.

This article has been cited by other articles:

				B. Donaubauer, T. Busch, R. Lachmann, M. Deja, B. Petersen, R. Francis, A. Trager, M. Ebsen, W. Boemke, and U. Kaisers Low-Dose Inhalation of an Endothelin-A Receptor Antagonist in Experimental Acute Lung Injury: ET-1 Plasma Concentration and Pulmonary Inflammation. Experimental Biology and Medicine, June 1, 2006; 231(6): 960 - 966. [Abstract] [Full Text] [PDF]

				S. J. Getting, C. Di Filippo, C. W. Lam, F. Rossi, and M. D'Amico Investigation into the Potential Anti-Inflammatory Effects of Endothelin Antagonists in a Murine Model of Experimental Monosodium Urate Peritonitis J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 90 - 97. [Abstract] [Full Text] [PDF]

				A. L. F. Sampaio, G. A. Rae, and M. d. G. M. O. Henriques Effects of endothelin ETA receptor antagonism on granulocyte and lymphocyte accumulation in LPS-induced inflammation J. Leukoc. Biol., July 1, 2004; 76(1): 210 - 216. [Abstract] [Full Text] [PDF]

				P. J. Henry, T. S. Mann, A. C. D'Aprile, G. J. Self, and R. G. Goldie An endothelin receptor antagonist, SB-217242, inhibits airway hyperresponsiveness in allergic mice Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1072 - L1078. [Abstract] [Full Text] [PDF]

				R. K. Kumar and P. S. Foster Modeling Allergic Asthma in Mice: Pitfalls and Opportunities Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 267 - 272. [Abstract] [Full Text]

				M. T. Borchers, P. J. Justice, T. Ansay, V. Mancino, M. P. McGarry, J. Crosby, M. I. Simon, N. A. Lee, and J. J. Lee Gq Signaling Is Required for Allergen-Induced Pulmonary Eosinophilia J. Immunol., April 1, 2002; 168(7): 3543 - 3549. [Abstract] [Full Text] [PDF]

				P. Cui, K. Tani, H. Kitamura, Y. Okumura, M. Yano, D. Inui, T. Tamaki, S. Sone, and H. Kido A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes J. Leukoc. Biol., August 1, 2001; 70(2): 306 - 312. [Abstract] [Full Text] [PDF]

				F. Finsnes, T. Lyberg, G. Christensen, and O. H. Skjonsberg Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L659 - L665. [Abstract] [Full Text] [PDF]

				M. Salmon, Y.-C. Liu, J. C. W. Mak, J. Rousell, T.-J. Huang, T. Hisada, P. L. Nicklin, and K. Fan Chung Contribution of Upregulated Airway Endothelin-1 Expression to Airway Smooth Muscle and Epithelial Cell DNA Synthesis after Repeated Allergen Exposure of Sensitized Brown-Norway Rats Am. J. Respir. Cell Mol. Biol., November 1, 2000; 23(5): 618 - 625. [Abstract] [Full Text]

				Y. Sato, J. C. Hogg, D. English, and S. F. van Eeden Endothelin-1 Changes Polymorphonuclear Leukocytes' Deformability and CD11b Expression and Promotes Their Retention in the Lung Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 404 - 410. [Abstract] [Full Text]

				T. C. Carpenter and K. R. Stenmark Endothelin receptor blockade decreases lung water in young rats exposed to viral infection and hypoxia Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L547 - L554. [Abstract] [Full Text] [PDF]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]